Hikma moves into Morocco with $111M deal

Jordan's Hikma Pharmaceuticals has made its first foray into Morocco with a $111 million deal for controlling interest in Promopharm, the country's 9th-largest drugmaker with 200 branded generics and in-licensed products. The company plans to introduce about 20 Hikma products into the market as well. Report

Suggested Articles

The FDA has granted Amarin's Vascepa a possible blockbuster label expansion for CV risk reduction in patients with or without CV disease.

In a high-stakes patent lawsuit between CAR-T companies Bristol-Myers Squibb and Gilead Sciences, BMS has come up with a victory. 

It’s been a year of ups and downs for Pfizer’s Xeljanz. But the company is hoping to close on a high note, with help from a new extended-release pill.